123 related articles for article (PubMed ID: 8536346)
1. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
[TBL] [Abstract][Full Text] [Related]
2. Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665.
Seki T; Kanada A; Nakao T; Shiraiwa M; Asano H; Miyazawa K; Ishimori T; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):84-96. PubMed ID: 9468640
[TBL] [Abstract][Full Text] [Related]
3. Studies on agents with vasodilator and beta-blocking activities. I.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
[TBL] [Abstract][Full Text] [Related]
4. Studies on agents with vasodilator and beta-blocking activities. IV.
Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
[TBL] [Abstract][Full Text] [Related]
6. Studies on agents with vasodilator and beta-blocking activities. II.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
[TBL] [Abstract][Full Text] [Related]
8. 4,5-disubstituted pyridazin-3(2H)-ones as hypotensive drugs: incorporation of a beta-blocking moiety.
Gómez-Gil MC; Gómez-Parra V; Sánchez F; Torres T
Arch Pharm (Weinheim); 1986 Jan; 319(1):60-4. PubMed ID: 2870697
[No Abstract] [Full Text] [Related]
9. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
[No Abstract] [Full Text] [Related]
10. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
Owen DA; Eden RJ; Lamb MS; Taylor EM
J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
[TBL] [Abstract][Full Text] [Related]
13. Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
Baldwin JJ; Lumma WC; Lundell GF; Ponticello GS; Raab AW; Engelhardt EL; Hirschmann R; Sweet CS; Scriabine A
J Med Chem; 1979 Nov; 22(11):1284-90. PubMed ID: 42797
[No Abstract] [Full Text] [Related]
14. Antihypertensive and vasorelaxing activities of synthetic xanthone derivatives.
Wang LW; Kang JJ; Chen IJ; Teng CM; Lin CN
Bioorg Med Chem; 2002 Mar; 10(3):567-72. PubMed ID: 11814844
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
Uchida W; Shibasaki K; Asano M; Takenaka T
Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of hydrazine pyridazine with hypotensive activity. II].
Bellasio E; Ripamonti A; Parravicini F; Baldoli E
Farmaco Sci; 1972 Jul; 27(7):591-600. PubMed ID: 5079482
[No Abstract] [Full Text] [Related]
18. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.
Navarrete-Vázquez G; Hidalgo-Figueroa S; Torres-Piedra M; Vergara-Galicia J; Rivera-Leyva JC; Estrada-Soto S; León-Rivera I; Aguilar-Guardarrama B; Rios-Gómez Y; Villalobos-Molina R; Ibarra-Barajas M
Bioorg Med Chem; 2010 Jun; 18(11):3985-91. PubMed ID: 20451399
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
Boucher M; Dubray C; Duchêne-Marullaz P
J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
